The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).
 
Peter S. Grimison
Research Funding - ASLAN Pharmaceuticals (Inst); Boston Biomedical (Inst); Eisai (Inst); Eisai (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Halozyme (Inst); Medimmune; MSD (Inst); Pfizer (Inst); Pfizer (Inst); Specialised Therapeutics; Tigermed (Inst); Tilray (Inst); Zucero Therapeutics
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - Medivation/Pfizer
 
Adrienne Kirby
No Relationships to Disclose
 
Anna Walsh
No Relationships to Disclose
 
Nicholas Lintzeris
Consulting or Advisory Role - Camurus; Indivumed; Mundipharma
Speakers' Bureau - PCM Healthcare Ltd
Research Funding - Camurus (Inst)
 
Yvonne Cheung
No Relationships to Disclose
 
Antony Mersiades
Travel, Accommodations, Expenses - Roche
 
Annette Tognela
Travel, Accommodations, Expenses - Ipsen
 
Paul Haber
No Relationships to Disclose
 
John Simes
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst)
 
Rachael L. Morton
Research Funding - Edwards Lifesciences (Inst)
 
Ian N. Olver
Consulting or Advisory Role - Aucentra Therapeutics; Con Ca Pty Ltd; VieCure
Speakers' Bureau - Pierre Fabre (Inst)
 
Iain McGregor
Honoraria - Janssen
Patents, Royalties, Other Intellectual Property - Kinoxis Therapeutics
 
Craig Gedye
Honoraria - Novotech
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Novotech; Pfizer (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Merck Sharp & Dohme
 
Peter Fox
No Relationships to Disclose
 
Karen P. Briscoe
No Relationships to Disclose
 
Morteza Aghmesheh
No Relationships to Disclose
 
Ehtesham A. Abdi
No Relationships to Disclose
 
Stephen John Clarke
Employment - GenesisCare
Stock and Other Ownership Interests - GenesisCare
Honoraria - Tetra Health
Consulting or Advisory Role - AllVascular; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bayer; Ipsen; Merck
Speakers' Bureau - Merck; Novartis/Ipsen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedLab
 
Stephen Della-Fiorentina
No Relationships to Disclose